Process for the manufacture of HMG- CoA reductase inhibitors

Details for Australian Patent Application No. 2003226971 (hide)

Owner Novartis AG

Inventors Acemoglu, Murat; Riss, Bernhard

Agent Davies Collison Cave

Pub. Number AU-B-2003226971

PCT Number PCT/EP03/00954

PCT Pub. Number WO2003/064392

Priority 60/353,787 31.01.02 US

Filing date 30 January 2003

Wipo publication date 2 September 2003

Acceptance publication date 30 November 2006

International Classifications

C07D 215/14 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07B 53/00 (2006.01) Asymmetric syntheses

C07D 209/18 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 405/06 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

7 August 2003 Complete Application Filed

  Priority application(s): 60/353,787 31.01.02 US

18 September 2003 Application Open to Public Inspection

  Published as AU-B-2003226971

30 November 2006 Application Accepted

  Published as AU-B-2003226971

29 March 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003226972-A DRIVER FOR AT LEAST THREE ELECTRICAL LOADS, ESPECIALLY FOR ELECTROLUMINESCENT LIGTH SOURCES

2003226970-DISTANCE MEASURING DEVICE AND METHOD FOR DETERMINING A DISTANCE